ValiRx
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ValiRx generated cash of -$1,772,351, which is less than the previous year. Cash used in financing activities reached the amount of $1,115,739 last year. Net change in cash is therefore -$962,793.
Cash Flow
| 2014 | -3.00M | 62.13K | 2.43M |
|---|---|---|---|
| 2015 | -2.59M | -311.33K | 2.68M |
| 2016 | -4.21M | 635.46K | 3.90M |
| 2017 | -2.35M | -206.23K | 2.69M |
| 2018 | -3.35M | -324.02K | 3.34M |
| 2019 | -1.34M | -250.25K | 1.21M |
| 2020 | -1.91M | -91.28K | 3.85M |
| 2021 | -1.26M | 0 | 7.34K |
| 2022 | -1.71M | 0 | 2.25M |
| 2023 | -1.77M | -306.18K | 1.11M |
VAL.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.13M | 593.67K | 1.84M | -5.63K | 372.87K | 701.41K | 560.76K | 232.46K | 452.82K | 960.26K |
Operating activities | ||||||||||
Net income | -2.29M | -2.59M | -1.67M | -1.65M | -2.69M | -3.86M | -3.12M | -4.52M | -3.02M | -3.13M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 254.20K | 211.93K | 228.78K | 229.49K | 400.51K | 142.98K | 187.68K | 102.83K | 102.73K | 91.21K |
Stock-based compensation expense | 36.93K | 539.79K | 184.61K | 0 | 212.5K | 0 | 0 | 127.93K | 49.37K | 89.32K |
| Deferred income tax benefit | 36.93K | 539.79K | 184.61K | 0 | 212.5K | 0 | 0 | 127.93K | 49.37K | 89.32K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -13.80K | -60.88K | -6.19K | 23.34K | 84.00K | -31.99K | 14.46K | -1.07M | 94.66K | 0 |
Inventories | -69.00K | 0 | 0 | 0 | 0 | 0 | 0 | 11.73K | -32.8K | -7.07K |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.07M | -94.66K | 0 |
Cash generated by operating activities | -1.77M | -1.71M | -1.26M | -1.91M | -1.34M | -3.35M | -2.35M | -4.21M | -2.59M | -3.00M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -267.41K |
Investments In Property Plant And Equipment | -291.18K | 0 | 0 | -93.28K | -396.77K | -324.02K | -280.32K | -386.62K | -421.59K | -275.25K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 73.59K | 1.21M | 110.26K | 63 |
Cash generated by investing activities | -306.18K | 0 | 0 | -91.28K | -250.25K | -324.02K | -206.23K | 635.46K | -311.33K | 62.13K |
Financing activities | ||||||||||
Common Stock Issued | 1.3M | 2.48M | 21.66K | 4.13M | 1.57M | 3.72M | 3.06M | 1.69M | 3.05M | 2.9M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -9.96K | -13.24K | -5.32K | -80K | -138K | -25K | -83.77K | -190.84K | 0 | 0 |
Cash used in financing activities | 1.11M | 2.25M | 7.34K | 3.85M | 1.21M | 3.34M | 2.69M | 3.90M | 2.68M | 2.43M |
Net Change In Cash | -962.79K | 543.80K | -1.25M | 1.85M | -378.50K | -328.53K | 140.64K | 328.29K | -220.35K | -507.44K |
Cash at end of period | 174.68K | 1.13M | 593.67K | 1.84M | -5.63K | 372.87K | 701.41K | 560.76K | 232.46K | 452.82K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |